Form 4: Immurcell Corp Director Acquires Stock Options

Sentiment:

Statement of Changes in Beneficial Ownership


Immurcell Corp director Bryan K. Gathagan acquired 10,000 stock options as compensation for board services.

Summary

  • Bryan K. Gathagan, a Director at Immurcell Corp, was granted 10,000 non-qualified stock options on April 16, 2025.
  • These options have an exercise price of $5.49 per share and are exercisable starting April 16, 2028, with an expiration date of April 16, 2030.
  • The options were granted as compensation for services rendered on the Issuer's board of directors.
  • Following the grant, Gathagan beneficially owns 10,000 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily details routine director compensation rather than significant financial or strategic developments.

Positives

  • Director compensation through stock options aligns management incentives with shareholder value.
  • The grant of options indicates continued commitment from board members.
  • The exercise price of $5.49 suggests a belief in future stock price appreciation.

Negatives

  • The filing does not provide details on the company's financial performance or operational updates, focusing solely on a director's compensation.
  • The value of the options is contingent on future stock performance, which is not guaranteed.

Risks

  • The value of the stock options is subject to market volatility and the company's future performance.
  • If the company's stock price does not exceed the exercise price of $5.49, the options may expire worthless.

Future Outlook

The future outlook for the stock options is dependent on the company's stock performance exceeding the $5.49 exercise price by April 16, 2030.

Management Comments

  • The options were granted by the Issuer to compensate directors for services on the Issuer's board of directors.

Industry Context

StockSavvy.ai notes that the issuance of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors to attract and retain experienced leadership, aligning their interests with long-term shareholder value creation.

Related Party Transactions

  • Grant of 10,000 stock options to Director Bryan K. Gathagan as compensation for board services.

Stakeholder Impact

  • Shareholders: The alignment of director compensation with stock performance can be viewed positively, as it incentivizes directors to act in the best interest of shareholders.
  • Employees: This filing does not directly impact employees.

Next Steps

  • Bryan K. Gathagan may exercise the stock options starting April 16, 2028, if the stock price is favorable.
  • The options will expire on April 16, 2030, if not exercised.

Key Dates

DateDescription
04/16/2025Transaction Date (Grant of Stock Options)
04/16/2028Date Exercisable for Stock Options
04/16/2030Expiration Date for Stock Options
04/14/2026Signature Date

Keywords

Immurcell Corp, ICCC, Form 4, Stock Options, Director Compensation, Beneficial Ownership, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.